EyePoint Reports $95.6 Million Q3 Net Loss and Prioritizes DME Program
EyePoint reported third-quarter 2026 revenue of $0.8 million and a net loss of $95.6 million, or $1.07 per diluted share. Cash, cash equivalents and marketable securities totaled $118 million at quarter-end, and the company expects its funding and planned operational adjustments to support operatio…